Pharmaceutical

Alltrna plans to tackle rare diseases using tRNA-based therapies

Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases together.

Mar 1, 2025 - 06:00
Alltrna plans to tackle rare diseases using tRNA-based therapies
Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases together.
Read the original article

Tags:

Previous Article

Exelixis focuses on future growth despite COSMIC-313 trial challenges

Next Article

Zevra sells priority review voucher for $150m to support drug launches

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Access to new tools to combat RSV in babies likely to prove challenging

Access to new tools to combat RSV in babies likely to p...

Oct 6, 2023

STAT+: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

STAT+: Illumina says it will divest Grail, starting a c...

Dec 17, 2023

Opinion: Millions of people take birth control to treat endometriosis — but it doesn’t work

Opinion: Millions of people take birth control to treat...

Apr 5, 2023